The analysis of a larger number of cases of CMT involving GDAP1 mutations, along with detailed clinical, electrophysiological and pathological data, will be required to establish a reliable relationship between the genotype and phenotype of the different forms of the disease. This evidence concerns the gene GDAP1 and Charcot-Marie-Tooth disease.